Professor John Fraser presents latest ICU care in Abu Dhabi
February 1, 2022
Our Company Founder Professor John Fraser presented to ICU intensivists and clinicians at Cleveland Clinic in Abu Dhabi.
He outlined the latest thinking in ICU care and described concepts on the ICU room of the future, specifically designed to shorten required ICU care and improving patient outcomes.
About DMC
DMC is a clinical stage medtech company founded in Brisbane, Australia by globally recognised intensive care specialist, researcher, entrepreneur and founder Professor John Fraser AO.
DMC is developing a proprietary inhaled drug delivery platform for use in critical care emergencies. Our lead asset is an investigational inhaled epinephrine product to treat anaphylaxis.
DMC has a strong suite of intellectual property portfolio protecting both its inhaled drug delivery platform and therapeutic formulations. To date, DMC has raised more than AU$30 million from both private and public sector investors.
